DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE

DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE was reported 3503 times

DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PHARYNGEAL EXFOLIATION 2 0.5000
1 DIABETIC DYSLIPIDAEMIA 2 0.2000
2 FUNGAL BALANITIS 2 0.1111
3 PERINEAL CELLULITIS 5 0.0847
4 LOCOMOTIVE SYNDROME 2 0.0541
5 DEGENERATIVE AORTIC VALVE DISEASE 3 0.0448
6 PERINEAL SWELLING 2 0.0417
7 ACQUIRED PHIMOSIS 4 0.0336
8 EMPHYSEMATOUS PYELONEPHRITIS 6 0.0328
9 BALANITIS CANDIDA 4 0.0312
10 TESTIS DISCOMFORT 3 0.0303
11 HAEMORRHAGIC NECROTIC PANCREATITIS 2 0.0267
12 PERINEAL ABSCESS 12 0.0266
13 GENITAL DISORDER 3 0.0224
14 GENITAL ABSCESS 9 0.0223
15 DIABETIC KETOACIDOTIC HYPERGLYCAEMIC COMA 4 0.0220
16 BARTHOLINITIS 2 0.0215
17 PH URINE DECREASED 2 0.0200
18 PHIMOSIS 13 0.0176
19 BALANOPOSTHITIS 14 0.0170
20 SCROTAL ABSCESS 6 0.0159
21 MENINGOENCEPHALITIS BACTERIAL 2 0.0135
22 ECG SIGNS OF MYOCARDIAL ISCHAEMIA 3 0.0132
23 KETOACIDOSIS 98 0.0131
24 NECROTISING SOFT TISSUE INFECTION 3 0.0130
25 KETONURIA 10 0.0123
26 ANAEMIA VITAMIN B12 DEFICIENCY 6 0.0121
27 KETOSIS 13 0.0120
28 EUGLYCAEMIC DIABETIC KETOACIDOSIS 49 0.0119
29 BLOOD KETONE BODY INCREASED 9 0.0115
30 BLOOD ALKALINE PHOSPHATASE 2 0.0108
31 HYPEROSMOLAR STATE 3 0.0104
32 GLUCOCORTICOID DEFICIENCY 4 0.0095
33 GENITAL CANDIDIASIS 2 0.0094
34 VULVITIS 3 0.0091
35 LICHEN SCLEROSUS 6 0.0088
36 NECROTISING FASCIITIS 29 0.0082
37 PENILE ERYTHEMA 3 0.0080
38 ACETONAEMIA 2 0.0079
39 DIABETIC KETOSIS 3 0.0079
40 GROIN ABSCESS 9 0.0076
41 DIABETIC KETOACIDOSIS 177 0.0074
42 GENITAL DISCOMFORT 4 0.0072
43 DIABETIC METABOLIC DECOMPENSATION 10 0.0072
44 GENITOURINARY TRACT INFECTION 2 0.0071
45 URINE KETONE BODY PRESENT 11 0.0070
46 HYPOCHROMIC ANAEMIA 7 0.0069
47 PHARYNGEAL INFLAMMATION 8 0.0066
48 GASTRIC HYPOMOTILITY 2 0.0065
49 SEXUALLY INAPPROPRIATE BEHAVIOUR 3 0.0064
50 INCREASED DOSE ADMINISTERED 2 0.0064
51 NAIL BED INFLAMMATION 2 0.0063
52 ANTICOAGULATION DRUG LEVEL INCREASED 2 0.0062
53 PENILE OEDEMA 2 0.0061
54 GENITAL INFECTION 2 0.0061
55 GENITAL INFECTION FUNGAL 5 0.0061
56 ABSCESS NECK 4 0.0059
57 GLUCOSE URINE PRESENT 7 0.0055
58 VANISHING BILE DUCT SYNDROME 6 0.0054
59 MICROALBUMINURIA 4 0.0053
60 ACCELERATED HYPERTENSION 2 0.0053
61 LIPID METABOLISM DISORDER 2 0.0052
62 DEBRIDEMENT 4 0.0052
63 MITRAL VALVE STENOSIS 3 0.0045
64 GLYCOSURIA 6 0.0044
65 BODY MASS INDEX DECREASED 2 0.0043
66 PRURITUS GENITAL 10 0.0042
67 GLYCOSYLATED HAEMOGLOBIN ABNORMAL 5 0.0042
68 IMMUNE-MEDIATED THYROIDITIS 2 0.0040
69 GENITAL ERYTHEMA 2 0.0040
70 LEFT VENTRICULAR DILATATION 2 0.0039
71 GLYCOSYLATED HAEMOGLOBIN INCREASED 88 0.0035
72 HAEMATOMA INFECTION 2 0.0035
73 DYSENTERY 6 0.0032
74 EXCESSIVE CERUMEN PRODUCTION 2 0.0032
75 AMPUTATION 4 0.0032
76 CORTISOL INCREASED 2 0.0032
77 DRY GANGRENE 2 0.0031
78 PRODUCT RESIDUE PRESENT 17 0.0031
79 HYPERCHLORAEMIA 2 0.0031
80 NEUROPATHIC ARTHROPATHY 2 0.0031
81 CARDIAC ANEURYSM 3 0.0030
82 HYPOGONADISM 3 0.0030
83 DIABETES MELLITUS INADEQUATE CONTROL 52 0.0029
84 PRODUCT BLISTER PACKAGING ISSUE 3 0.0029
85 ORCHITIS 3 0.0028
86 FINGER AMPUTATION 2 0.0027
87 PERIRECTAL ABSCESS 3 0.0027
88 KLEBSIELLA SEPSIS 3 0.0027
89 IMPAIRED GASTRIC EMPTYING 36 0.0026
90 GENITAL ULCERATION 2 0.0026
91 EPIDIDYMITIS 3 0.0026
92 TOE AMPUTATION 13 0.0026
93 GLYCOSYLATED HAEMOGLOBIN DECREASED 4 0.0025
94 PENILE SWELLING 3 0.0024
95 BLOOD GLUCOSE ABNORMAL 45 0.0024
96 POLYCYTHAEMIA 5 0.0024
97 GLOMERULAR FILTRATION RATE INCREASED 2 0.0024
98 MICROCYTIC ANAEMIA 5 0.0024
99 POLYURIA 19 0.0023
100 LACTIC ACIDOSIS 75 0.0023
101 DEVICE LOOSENING 2 0.0023
102 GENITAL BURNING SENSATION 2 0.0023
103 ENDOCRINE OPHTHALMOPATHY 2 0.0023
104 DIABETIC FOOT 7 0.0023
105 INTENTIONAL DEVICE MISUSE 10 0.0023
106 SCHIZOAFFECTIVE DISORDER 4 0.0022
107 CANDIDA SEPSIS 2 0.0022
108 ANAL ABSCESS 12 0.0022
109 VULVOVAGINAL CANDIDIASIS 3 0.0022
110 GASTROINTESTINAL HYPOMOTILITY 5 0.0022
111 VULVOVAGINAL PRURITUS 11 0.0022
112 METABOLIC ACIDOSIS 69 0.0022
113 HYPERTENSIVE HEART DISEASE 4 0.0021
114 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 3 0.0021
115 PERIPHERAL ARTERY OCCLUSION 3 0.0021
116 PRERENAL FAILURE 3 0.0021
117 GENITAL RASH 3 0.0021
118 FOOT AMPUTATION 3 0.0021
119 GENITAL PAIN 3 0.0020
120 BLOOD PARATHYROID HORMONE DECREASED 3 0.0020
121 PENIS DISORDER 5 0.0020
122 HEMIANOPIA 2 0.0020
123 BLADDER CANCER RECURRENT 2 0.0020
124 DILATED CARDIOMYOPATHY 2 0.0020
125 GASTROINTESTINAL VIRAL INFECTION 2 0.0019
126 OEDEMA MUCOSAL 2 0.0019
127 MEDICATION RESIDUE PRESENT 9 0.0019
128 AMAUROSIS FUGAX 2 0.0019
129 NEAR DEATH EXPERIENCE 6 0.0018
130 CLOSTRIDIUM TEST POSITIVE 4 0.0018
131 ARTHROPOD STING 3 0.0018
132 MITRAL VALVE PROLAPSE 3 0.0018
133 LARYNGEAL CANCER 2 0.0018
134 GLOMERULAR FILTRATION RATE DECREASED 22 0.0018
135 RECTAL ABSCESS 3 0.0018
136 LAZINESS 3 0.0018
137 CENTRAL NERVOUS SYSTEM INFECTION 2 0.0017
138 DENGUE FEVER 4 0.0017
139 BLOOD CREATININE ABNORMAL 6 0.0017
140 PYELONEPHRITIS 15 0.0017
141 VERTIGO POSITIONAL 3 0.0017
142 BLOOD TRIGLYCERIDES INCREASED 30 0.0017
143 COLORECTAL CANCER METASTATIC 4 0.0017
144 ABSCESS LIMB 7 0.0016
145 DIABETIC NEUROPATHY 8 0.0016
146 TACHYARRHYTHMIA 4 0.0016
147 ABORTION MISSED 2 0.0016
148 ACIDOSIS 12 0.0016
149 LEFT ATRIAL DILATATION 2 0.0016
150 VULVOVAGINAL DRYNESS 5 0.0015
151 FUNGAL INFECTION 51 0.0015
152 PYELONEPHRITIS ACUTE 3 0.0015
153 UROSEPSIS 14 0.0015
154 HYPERGLYCAEMIA 55 0.0015
155 GASTROENTERITIS NOROVIRUS 2 0.0015
156 LIP EXFOLIATION 2 0.0015
157 ANION GAP INCREASED 2 0.0015
158 BODY MASS INDEX INCREASED 2 0.0015
159 ATRIAL TACHYCARDIA 3 0.0014
160 DIABETIC FOOT INFECTION 2 0.0014
161 BLADDER TRANSITIONAL CELL CARCINOMA 2 0.0014
162 BLOOD GLUCOSE FLUCTUATION 15 0.0014
163 DIABETIC NEPHROPATHY 3 0.0014
164 BILIARY DILATATION 2 0.0014
165 CHRONIC GASTRITIS 3 0.0013
166 GANGRENE 8 0.0013
167 RENAL COLIC 3 0.0013
168 URINE ABNORMALITY 6 0.0013
169 PROSTATITIS 4 0.0013
170 MYOGLOBIN BLOOD INCREASED 2 0.0013
171 FLAT AFFECT 3 0.0013
172 INJECTION SITE NODULE 14 0.0013
173 VULVOVAGINAL MYCOTIC INFECTION 5 0.0013
174 LIMB DEFORMITY 2 0.0013
175 BLOOD GLUCOSE INCREASED 232 0.0012
176 BREATH ODOUR 3 0.0012
177 INJECTION SITE EXTRAVASATION 15 0.0012
178 HYPERVENTILATION 7 0.0012
179 MYOCARDIAL NECROSIS MARKER INCREASED 2 0.0012
180 OSTEITIS 3 0.0012
181 DIABETIC RETINOPATHY 4 0.0012
182 BLADDER NEOPLASM 2 0.0012
183 BLOOD PH DECREASED 2 0.0012
184 PANCREATITIS ACUTE 26 0.0012
185 EXTREMITY NECROSIS 2 0.0011
186 MICTURITION URGENCY 13 0.0011
187 PANCREATIC FAILURE 2 0.0011
188 BLOOD POTASSIUM ABNORMAL 3 0.0011
189 DRUG MONITORING PROCEDURE NOT PERFORMED 2 0.0011
190 HYPOGLYCAEMIA 54 0.0011
191 INABILITY TO AFFORD MEDICATION 11 0.0011
192 INFECTED SKIN ULCER 2 0.0011
193 ARTERIAL DISORDER 2 0.0010
194 ATRIOVENTRICULAR BLOCK COMPLETE 7 0.0010
195 LIPASE INCREASED 8 0.0010
196 HYPOGLYCAEMIC COMA 3 0.0010
197 EARLY SATIETY 2 0.0010
198 GALLBLADDER INJURY 2 0.0010
199 PROSTATOMEGALY 4 0.0010
200 SKIN ODOUR ABNORMAL 4 0.0010
201 POLYDIPSIA 4 0.0010
202 HYPOGLYCAEMIC UNCONSCIOUSNESS 2 0.0010
203 THIRST 18 0.0010
204 HUNGER 14 0.0010
205 MUCOSAL DRYNESS 2 0.0010
206 PRODUCT SOLUBILITY ABNORMAL 5 0.0010
207 EYE INJURY 3 0.0010
208 NIPPLE PAIN 2 0.0010
209 LEG AMPUTATION 4 0.0010
210 BLOOD CHOLESTEROL INCREASED 45 0.0010
211 POLLAKIURIA 40 0.0010
212 LIVEDO RETICULARIS 2 0.0010
213 BLOOD LACTIC ACID INCREASED 5 0.0009
214 TONGUE DISCOMFORT 4 0.0009
215 ESCHERICHIA URINARY TRACT INFECTION 4 0.0009
216 INFUSION SITE BRUISING 2 0.0009
217 HENOCH-SCHONLEIN PURPURA 2 0.0009
218 FAECALOMA 5 0.0009
219 LISTLESS 3 0.0009
220 CARDIAC FAILURE ACUTE 6 0.0009
221 DYSURIA 33 0.0009
222 CALCINOSIS 2 0.0009
223 HAEMATOCRIT INCREASED 2 0.0009
224 ORAL PRURITUS 2 0.0009
225 MICTURITION DISORDER 3 0.0009
226 ESCHERICHIA BACTERAEMIA 2 0.0008
227 PANCREATITIS CHRONIC 2 0.0008
228 CHOLECYSTITIS 10 0.0008
229 VULVOVAGINAL PAIN 4 0.0008
230 GLOMERULONEPHRITIS 2 0.0008
231 ANURIA 7 0.0008
232 SENSITIVE SKIN 6 0.0008
233 BREATH SOUNDS ABNORMAL 4 0.0008
234 CARDIAC DYSFUNCTION 3 0.0008
235 HYPERKALAEMIA 28 0.0008
236 KLEBSIELLA INFECTION 4 0.0008
237 HYPOMAGNESAEMIA 11 0.0008
238 HAEMODYNAMIC INSTABILITY 6 0.0008
239 MENOPAUSE 2 0.0008
240 DRUG TITRATION ERROR 2 0.0008
241 TYPE 2 DIABETES MELLITUS 26 0.0008
242 SKIN NECROSIS 4 0.0008
243 CHOKING 15 0.0008
244 EPIGASTRIC DISCOMFORT 3 0.0008
245 HEPATITIS TOXIC 2 0.0008
246 ARTERIAL OCCLUSIVE DISEASE 6 0.0008
247 HYPERSENSITIVITY VASCULITIS 2 0.0008
248 IRON DEFICIENCY ANAEMIA 7 0.0008
249 TRICUSPID VALVE INCOMPETENCE 6 0.0008
250 APPETITE DISORDER 5 0.0008
251 HEPATIC STEATOSIS 14 0.0008
252 HYPERLACTACIDAEMIA 2 0.0007
253 ARTERIOSCLEROSIS 7 0.0007
254 GASTROINTESTINAL INJURY 2 0.0007
255 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 3 0.0007
256 PERIPHERAL ISCHAEMIA 3 0.0007
257 ORAL FUNGAL INFECTION 2 0.0007
258 INSURANCE ISSUE 11 0.0007
259 HYPERTENSIVE CRISIS 8 0.0007
260 NECROSIS 4 0.0007
261 ACUTE KIDNEY INJURY 109 0.0007
262 PANCREATIC CARCINOMA METASTATIC 2 0.0007
263 PANCREATITIS 37 0.0007
264 DERMATITIS BULLOUS 5 0.0007
265 DIVERTICULUM INTESTINAL 3 0.0007
266 BLOOD CALCIUM INCREASED 6 0.0007
267 BLOOD GLUCOSE DECREASED 32 0.0007
268 TYPE 1 DIABETES MELLITUS 4 0.0007
269 SUSPECTED OFF LABEL USE 3 0.0007
270 PENILE PAIN 2 0.0007
271 INTRACARDIAC THROMBUS 2 0.0007
272 DIASTOLIC DYSFUNCTION 2 0.0006
273 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 5 0.0006
274 WEIGHT DECREASED 178 0.0006
275 PRODUCT ADMINISTRATION INTERRUPTED 5 0.0006
276 SARCOIDOSIS 3 0.0006
277 RENAL CYST 5 0.0006
278 HEPATIC CYTOLYSIS 8 0.0006
279 SUBCUTANEOUS ABSCESS 3 0.0006
280 DEVICE LEAKAGE 27 0.0006
281 LOOSE TOOTH 2 0.0006
282 HAEMATURIA 21 0.0006
283 RETCHING 13 0.0006
284 PHOTOSENSITIVITY REACTION 10 0.0006
285 GASTROINTESTINAL SOUNDS ABNORMAL 3 0.0006
286 HIGH DENSITY LIPOPROTEIN DECREASED 2 0.0006
287 FLUID INTAKE REDUCED 3 0.0006
288 LEFT VENTRICULAR DYSFUNCTION 4 0.0006
289 DYSLIPIDAEMIA 3 0.0006
290 ENDOCARDITIS 3 0.0006
291 PRODUCT COLOUR ISSUE 3 0.0006
292 HEPATIC FIBROSIS 2 0.0006
293 INTENTIONAL PRODUCT MISUSE 51 0.0006
294 HAIR GROWTH ABNORMAL 4 0.0006
295 SEPTIC SHOCK 25 0.0006
296 URINE OUTPUT DECREASED 5 0.0006
297 FOOD CRAVING 3 0.0006
298 RENAL PAIN 6 0.0006
299 THERMAL BURN 4 0.0006
300 GLOSSITIS 2 0.0006
301 OVERWEIGHT 3 0.0006
302 ANAL INCONTINENCE 5 0.0006
303 ASTHMATIC CRISIS 2 0.0005
304 ACCIDENTAL OVERDOSE 20 0.0005
305 PROSTATIC DISORDER 3 0.0005
306 FEEDING DISORDER 11 0.0005
307 AMYLASE INCREASED 2 0.0005
308 INJECTION SITE MASS 20 0.0005
309 INCORRECT DOSE ADMINISTERED BY DEVICE 14 0.0005
310 CHOLECYSTITIS ACUTE 3 0.0005
311 RECALLED PRODUCT ADMINISTERED 5 0.0005
312 SHOCK 12 0.0005
313 MOUTH SWELLING 3 0.0005
314 THROMBOTIC MICROANGIOPATHY 5 0.0005
315 CARDIOPULMONARY FAILURE 2 0.0005
316 HYPOVOLAEMIA 3 0.0005
317 PHARYNGEAL SWELLING 5 0.0005
318 THERAPY CHANGE 5 0.0005
319 HEPATITIS 13 0.0005
320 OESOPHAGEAL PAIN 2 0.0005
321 IDIOPATHIC PULMONARY FIBROSIS 2 0.0005
322 LIGAMENT SPRAIN 5 0.0005
323 PLEURISY 3 0.0005
324 RENAL INJURY 15 0.0005
325 HYPERLIPIDAEMIA 6 0.0005
326 WOUND 14 0.0005
327 AZOTAEMIA 2 0.0005
328 CARPAL TUNNEL SYNDROME 7 0.0005
329 GASTRITIS 13 0.0005
330 ASPHYXIA 4 0.0005
331 PERIPHERAL VENOUS DISEASE 2 0.0005
332 URINARY TRACT INFECTION 83 0.0005
333 ESCHERICHIA INFECTION 4 0.0005
334 INFUSION SITE EXTRAVASATION 3 0.0005
335 GASTROENTERITIS 7 0.0005
336 WEIGHT FLUCTUATION 5 0.0005
337 BLOOD CREATININE INCREASED 31 0.0005
338 MUSCLE ATROPHY 6 0.0005
339 LIP OEDEMA 2 0.0005
340 HEPATIC PAIN 2 0.0005
341 LUNG NEOPLASM 2 0.0005
342 LEFT VENTRICULAR HYPERTROPHY 2 0.0005
343 PRESCRIBED OVERDOSE 9 0.0005
344 OCULAR ICTERUS 2 0.0005
345 MONOPLEGIA 2 0.0005
346 PRODUCT PRESCRIBING ISSUE 10 0.0005
347 CHOLELITHIASIS 15 0.0005
348 CELLULITIS 23 0.0005
349 GROIN PAIN 4 0.0005
350 NERVE INJURY 5 0.0004
351 ILEUS PARALYTIC 2 0.0004
352 NEEDLE ISSUE 13 0.0004
353 GASTROINTESTINAL INFECTION 4 0.0004
354 MENINGITIS ASEPTIC 2 0.0004
355 BLOOD CALCIUM DECREASED 5 0.0004
356 POSTOPERATIVE WOUND INFECTION 3 0.0004
357 TASTE DISORDER 9 0.0004
358 ULCER HAEMORRHAGE 3 0.0004
359 COMA 21 0.0004
360 BLOOD THYROID STIMULATING HORMONE DECREASED 2 0.0004
361 SEPSIS 49 0.0004
362 INFARCTION 3 0.0004
363 EAR DISORDER 2 0.0004
364 NEPHROLITHIASIS 20 0.0004
365 ONYCHOCLASIS 3 0.0004
366 DEHYDRATION 58 0.0004
367 NERVE COMPRESSION 4 0.0004
368 BLOOD CHOLESTEROL ABNORMAL 2 0.0004
369 LOCALISED OEDEMA 2 0.0004
370 ELECTROLYTE IMBALANCE 5 0.0004
371 CARDIAC FAILURE 34 0.0004
372 SPINAL DISORDER 4 0.0004
373 RESPIRATORY TRACT INFECTION 11 0.0004
374 PROTEINURIA 8 0.0004
375 PRODUCT SUPPLY ISSUE 3 0.0004
376 DIABETES MELLITUS 32 0.0004
377 TONGUE DISORDER 3 0.0004
378 CANDIDA INFECTION 7 0.0004
379 PRODUCT DOSE OMISSION 27 0.0004
380 FINGER DEFORMITY 2 0.0004
381 NOCTURIA 5 0.0004
382 LIQUID PRODUCT PHYSICAL ISSUE 3 0.0004
383 HEPATOMEGALY 4 0.0004
384 GENERALISED OEDEMA 5 0.0004
385 INFLAMMATORY MARKER INCREASED 2 0.0004
386 BLADDER DISORDER 4 0.0004
387 BLOOD PRESSURE ABNORMAL 8 0.0004
388 HYPERNATRAEMIA 2 0.0004
389 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 3 0.0004
390 EOSINOPHILIA 7 0.0004
391 ERYSIPELAS 2 0.0004
392 CORONARY ARTERY STENOSIS 2 0.0004
393 PEMPHIGOID 3 0.0004
394 PRODUCT ADMINISTRATION ERROR 8 0.0004
395 CORONARY ARTERIAL STENT INSERTION 2 0.0004
396 BOWEL MOVEMENT IRREGULARITY 3 0.0004
397 DRUG DELIVERY SYSTEM MALFUNCTION 2 0.0004
398 PERIPHERAL VASCULAR DISORDER 2 0.0004
399 LOW DENSITY LIPOPROTEIN INCREASED 3 0.0004
400 APHTHOUS ULCER 3 0.0004
401 HAEMORRHAGIC STROKE 3 0.0004
402 PLATELET COUNT INCREASED 5 0.0004
403 NODULE 5 0.0004
404 MALABSORPTION 2 0.0004
405 PRODUCT USE COMPLAINT 6 0.0004
406 VOMITING 179 0.0004
407 INJECTION SITE DISCOMFORT 4 0.0004
408 DECREASED APPETITE 88 0.0004
409 EYE HAEMORRHAGE 5 0.0004
410 BODY HEIGHT DECREASED 4 0.0004
411 FOOD POISONING 2 0.0004
412 SENSORY LOSS 3 0.0004
413 LOCALISED INFECTION 9 0.0004
414 INTESTINAL OBSTRUCTION 14 0.0004
415 URINARY INCONTINENCE 11 0.0004
416 MUSCLE DISORDER 3 0.0004
417 PRURITUS GENERALISED 8 0.0004
418 BLOOD POTASSIUM INCREASED 6 0.0004
419 HIP SURGERY 2 0.0004
420 LIMB INJURY 10 0.0004
421 BLINDNESS 15 0.0004
422 DYSPEPSIA 36 0.0004
423 CHOLESTASIS 7 0.0004
424 DEAFNESS UNILATERAL 2 0.0004
425 CHOKING SENSATION 2 0.0004
426 ACUTE CORONARY SYNDROME 3 0.0004
427 ERUCTATION 7 0.0004
428 ABDOMINAL PAIN 84 0.0004
429 RHABDOMYOLYSIS 15 0.0004
430 MALNUTRITION 4 0.0004
431 ANGIOPATHY 2 0.0004
432 FISTULA 4 0.0004
433 HYPONATRAEMIA 20 0.0004
434 EYE INFECTION 4 0.0004
435 PERIORBITAL SWELLING 2 0.0004
436 FLATULENCE 20 0.0004
437 ERECTILE DYSFUNCTION 9 0.0004
438 MYOCARDITIS 4 0.0003
439 MUSCLE STRAIN 3 0.0003
440 RENAL FAILURE 46 0.0003
441 BLOOD URIC ACID INCREASED 2 0.0003
442 RENAL IMPAIRMENT 29 0.0003
443 DRY MOUTH 28 0.0003
444 COLD SWEAT 6 0.0003
445 HYPERCHLORHYDRIA 2 0.0003
446 DECREASED INTEREST 2 0.0003
447 CONSTIPATION 73 0.0003
448 GOUT 6 0.0003
449 POLYNEUROPATHY 4 0.0003
450 HYPERTENSION 70 0.0003
451 RETINAL DETACHMENT 3 0.0003
452 INJECTION SITE HAEMORRHAGE 26 0.0003
453 LARYNGEAL OEDEMA 2 0.0003
454 PRODUCT DISPENSING ERROR 7 0.0003
455 NEPHROPATHY 3 0.0003
456 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 15 0.0003
457 HEPATIC CIRRHOSIS 6 0.0003
458 COVID-19 56 0.0003
459 CATARACT 19 0.0003
460 ARRHYTHMIA 15 0.0003
461 BLOOD URINE PRESENT 6 0.0003
462 OBESITY 5 0.0003
463 SCIATICA 5 0.0003
464 ABSCESS 5 0.0003
465 HYPOTHYROIDISM 10 0.0003
466 RASH PAPULAR 7 0.0003
467 PANCREATIC CARCINOMA 9 0.0003
468 TREATMENT NONCOMPLIANCE 17 0.0003
469 ANGINA UNSTABLE 2 0.0003
470 VISION BLURRED 42 0.0003
471 KIDNEY INFECTION 6 0.0003
472 IMPAIRED HEALING 10 0.0003
473 DYSGRAPHIA 2 0.0003
474 SARS-COV-2 TEST POSITIVE 4 0.0003
475 CORONAVIRUS INFECTION 2 0.0003
476 ARTERIOSCLEROSIS CORONARY ARTERY 2 0.0003
477 BLOOD POTASSIUM DECREASED 9 0.0003
478 HEPATIC FAILURE 9 0.0003
479 PRODUCT TASTE ABNORMAL 4 0.0003
480 GENERAL PHYSICAL CONDITION ABNORMAL 2 0.0003
481 NAUSEA 233 0.0003
482 MOTOR DYSFUNCTION 3 0.0003
483 SLUGGISHNESS 3 0.0003
484 PRODUCT PRESCRIBING ERROR 7 0.0003
485 BLOOD TESTOSTERONE DECREASED 2 0.0003
486 MOBILITY DECREASED 21 0.0003
487 DEVICE DELIVERY SYSTEM ISSUE 8 0.0003
488 SCAR 5 0.0003
489 NEPHROTIC SYNDROME 2 0.0003
490 BLOOD PRESSURE FLUCTUATION 7 0.0003
491 TEMPERATURE INTOLERANCE 3 0.0003
492 LARGE INTESTINE POLYP 2 0.0003
493 ABDOMINAL DISTENSION 30 0.0003
494 PRODUCT ODOUR ABNORMAL 3 0.0003
495 ABDOMINAL DISCOMFORT 48 0.0003
496 METASTASES TO LIVER 5 0.0003
497 SCRATCH 3 0.0003
498 INCONTINENCE 3 0.0003
499 SUDDEN DEATH 3 0.0003
500 OSTEOARTHRITIS 12 0.0003
501 SEASONAL ALLERGY 4 0.0003
502 HEPATOCELLULAR INJURY 4 0.0003
503 DIVERTICULUM 2 0.0003
504 ISCHAEMIC STROKE 5 0.0003
505 PARALYSIS 4 0.0003
506 RENAL DISORDER 13 0.0003
507 DECREASED ACTIVITY 3 0.0003
508 DISORIENTATION 11 0.0003
509 DIARRHOEA 179 0.0003
510 PANIC REACTION 2 0.0003
511 OSTEOMYELITIS 5 0.0003
512 CARDIOVASCULAR DISORDER 7 0.0003
513 FAECES SOFT 2 0.0003
514 C-REACTIVE PROTEIN INCREASED 10 0.0003
515 OESOPHAGITIS 3 0.0003
516 INTERVERTEBRAL DISC PROTRUSION 6 0.0003
517 APATHY 4 0.0003
518 UNDERDOSE 20 0.0003
519 ASPIRATION 3 0.0003
520 ORAL DISORDER 2 0.0003
521 DENTAL CARIES 3 0.0003
522 GAMMA-GLUTAMYLTRANSFERASE INCREASED 6 0.0003
523 DEVICE MALFUNCTION 19 0.0003
524 DRUG EFFECT LESS THAN EXPECTED 4 0.0003
525 NEOPLASM MALIGNANT 18 0.0003
526 FEELING DRUNK 2 0.0003
527 ASTHENIA 101 0.0003
528 PULMONARY MASS 4 0.0003
529 NECK PAIN 15 0.0003
530 ORAL PAIN 6 0.0003
531 HYDRONEPHROSIS 2 0.0003
532 ABDOMINAL PAIN UPPER 55 0.0003
533 PRODUCT USE ISSUE 50 0.0003
534 STATUS EPILEPTICUS 3 0.0003
535 HYPOCALCAEMIA 5 0.0003
536 PRODUCT AVAILABILITY ISSUE 6 0.0003
537 DEVICE FAILURE 4 0.0003
538 DISCOMFORT 16 0.0003
539 SLEEP APNOEA SYNDROME 5 0.0003
540 INCREASED APPETITE 5 0.0003
541 NEOPLASM 3 0.0003
542 FEAR 7 0.0003
543 SYNCOPE 26 0.0003
544 FREQUENT BOWEL MOVEMENTS 7 0.0003
545 LYMPHOMA 4 0.0003
546 EYELID OEDEMA 3 0.0003
547 BLOOD PRESSURE SYSTOLIC INCREASED 5 0.0003
548 HYPERHIDROSIS 33 0.0003
549 SKIN FISSURES 5 0.0003
550 MULTIPLE ALLERGIES 2 0.0003
551 BLOOD IRON DECREASED 3 0.0003
552 ATAXIA 3 0.0003
553 INFLAMMATION 13 0.0003
554 GINGIVAL PAIN 2 0.0003
555 UPPER LIMB FRACTURE 5 0.0003
556 VISUAL IMPAIRMENT 31 0.0002
557 NERVOUSNESS 13 0.0002
558 BLOOD PRESSURE INCREASED 38 0.0002
559 FRUSTRATION TOLERANCE DECREASED 2 0.0002
560 BACK DISORDER 4 0.0002
561 INTENTIONAL DOSE OMISSION 7 0.0002
562 ANGINA PECTORIS 7 0.0002
563 HYPERSOMNIA 7 0.0002
564 ABNORMAL FAECES 2 0.0002
565 CARDIOMEGALY 3 0.0002
566 SPINAL OPERATION 3 0.0002
567 EYE DISORDER 8 0.0002
568 TENDON RUPTURE 3 0.0002
569 HYPERCALCAEMIA 3 0.0002
570 ILLNESS 25 0.0002
571 INJECTION SITE DISCOLOURATION 3 0.0002
572 POISONING 3 0.0002
573 MUSCULAR WEAKNESS 27 0.0002
574 KNEE ARTHROPLASTY 5 0.0002
575 ACUTE MYOCARDIAL INFARCTION 7 0.0002
576 GASTROOESOPHAGEAL REFLUX DISEASE 19 0.0002
577 HYPOPHAGIA 6 0.0002
578 FACIAL PARALYSIS 2 0.0002
579 IMPAIRED WORK ABILITY 5 0.0002
580 THERAPY CESSATION 12 0.0002
581 ROTATOR CUFF SYNDROME 3 0.0002
582 RECTAL HAEMORRHAGE 10 0.0002
583 CARDIAC OPERATION 2 0.0002
584 HYPOACUSIS 10 0.0002
585 HIATUS HERNIA 3 0.0002
586 CONTRAINDICATED PRODUCT ADMINISTERED 7 0.0002
587 CARDIAC MURMUR 2 0.0002
588 MYOCARDIAL INFARCTION 40 0.0002
589 NAIL DISORDER 2 0.0002
590 ORAL CANDIDIASIS 3 0.0002
591 TOOTH INFECTION 3 0.0002
592 LUNG INFILTRATION 2 0.0002
593 DRUG ERUPTION 4 0.0002
594 INJECTION SITE BRUISING 18 0.0002
595 TRANSAMINASES INCREASED 5 0.0002
596 CHEST DISCOMFORT 23 0.0002
597 INJECTION SITE PRURITUS 15 0.0002
598 GASTROINTESTINAL DISORDER 20 0.0002
599 MYOSITIS 2 0.0002
600 HEART RATE INCREASED 22 0.0002
601 GASTROENTERITIS VIRAL 4 0.0002
602 CHROMATURIA 5 0.0002
603 HEART RATE IRREGULAR 5 0.0002
604 OEDEMA 12 0.0002
605 LEUKOCYTOSIS 4 0.0002
606 TOOTHACHE 4 0.0002
607 DRUG INTERACTION 35 0.0002
608 DIZZINESS 110 0.0002
609 RESTLESS LEGS SYNDROME 4 0.0002
610 EXOSTOSIS 2 0.0002
611 DEVICE MECHANICAL ISSUE 3 0.0002
612 CORONARY ARTERY OCCLUSION 3 0.0002
613 PNEUMONIA BACTERIAL 2 0.0002
614 PRODUCT DOSE OMISSION ISSUE 64 0.0002
615 INCREASED TENDENCY TO BRUISE 2 0.0002
616 PERSONALITY CHANGE 2 0.0002
617 APHONIA 3 0.0002
618 DEMENTIA 6 0.0002
619 MASS 3 0.0002
620 HEPATIC FUNCTION ABNORMAL 8 0.0002
621 TACHYCARDIA 19 0.0002
622 BLINDNESS UNILATERAL 3 0.0002
623 PHOTOPHOBIA 4 0.0002
624 MULTIPLE ORGAN DYSFUNCTION SYNDROME 6 0.0002
625 DRUG DOSE OMISSION 35 0.0002
626 CHRONIC KIDNEY DISEASE 16 0.0002
627 GAIT INABILITY 7 0.0002
628 LETHARGY 12 0.0002
629 BALANCE DISORDER 18 0.0002
630 HYPERTHYROIDISM 3 0.0002
631 ATELECTASIS 2 0.0002
632 CEREBROVASCULAR ACCIDENT 35 0.0002
633 CARDIAC ARREST 17 0.0002
634 PRESYNCOPE 5 0.0002
635 DISABILITY 4 0.0002
636 COLON CANCER 3 0.0002
637 OFF LABEL USE 176 0.0002
638 DEVICE ISSUE 18 0.0002
639 DYSPHAGIA 19 0.0002
640 BURNING SENSATION 14 0.0002
641 HYPOAESTHESIA ORAL 3 0.0002
642 MALAISE 87 0.0002
643 PRODUCT PHYSICAL ISSUE 4 0.0002
644 EMPHYSEMA 2 0.0002
645 BLOOD COUNT ABNORMAL 3 0.0002
646 ABDOMINAL PAIN LOWER 5 0.0002
647 URTICARIA 33 0.0002
648 EYELID PTOSIS 2 0.0002
649 TENDONITIS 3 0.0002
650 PETECHIAE 2 0.0002
651 DRUG-INDUCED LIVER INJURY 6 0.0002
652 FOLLICULITIS 2 0.0002
653 HEAD INJURY 6 0.0002
654 OEDEMA PERIPHERAL 23 0.0002
655 ULCER 3 0.0002
656 CYSTITIS 6 0.0002
657 GAIT DISTURBANCE 36 0.0002
658 EATING DISORDER 4 0.0002
659 FATIGUE 146 0.0002
660 SENSORY DISTURBANCE 3 0.0002
661 HEREDITARY ANGIOEDEMA 2 0.0002
662 DYSPNOEA EXERTIONAL 7 0.0002
663 POOR QUALITY SLEEP 4 0.0002
664 MUSCLE TIGHTNESS 3 0.0002
665 PHARYNGITIS STREPTOCOCCAL 2 0.0002
666 ALTERED STATE OF CONSCIOUSNESS 4 0.0002
667 FAECES DISCOLOURED 4 0.0002
668 MENTAL DISORDER 8 0.0002
669 FEELING ABNORMAL 44 0.0002
670 SKIN LESION 5 0.0002
671 PRURITUS 70 0.0002
672 VERTIGO 11 0.0002
673 FOOT DEFORMITY 2 0.0002
674 RASH MACULO-PAPULAR 4 0.0002
675 BLOOD UREA INCREASED 3 0.0002
676 WEIGHT INCREASED 40 0.0002
677 PARAESTHESIA 28 0.0002
678 HYPERSENSITIVITY 33 0.0002
679 ANGER 6 0.0002
680 MITRAL VALVE INCOMPETENCE 2 0.0002
681 CIRCULATORY COLLAPSE 3 0.0002
682 INJECTION SITE PAIN 54 0.0002
683 IMPAIRED DRIVING ABILITY 2 0.0002
684 MYOCARDIAL ISCHAEMIA 2 0.0002
685 DERMATITIS CONTACT 2 0.0002
686 INTERNAL HAEMORRHAGE 2 0.0002
687 TREMOR 29 0.0002
688 TINNITUS 8 0.0002
689 SKIN DISCOLOURATION 8 0.0002
690 METASTASES TO LUNG 2 0.0002
691 SYRINGE ISSUE 3 0.0002
692 DEPRESSION 39 0.0002
693 MYALGIA 29 0.0002
694 COVID-19 PNEUMONIA 2 0.0002
695 SWELLING FACE 11 0.0002
696 GALLBLADDER DISORDER 3 0.0002
697 THERAPY INTERRUPTED 12 0.0002
698 BACK PAIN 39 0.0002
699 CHEST PAIN 31 0.0002
700 RASH ERYTHEMATOUS 8 0.0002
701 MUSCLE RIGIDITY 2 0.0002
702 SKIN EXFOLIATION 14 0.0002
703 SUICIDE ATTEMPT 10 0.0002
704 ADRENAL INSUFFICIENCY 2 0.0002
705 BONE DISORDER 3 0.0002
706 PERIPHERAL SWELLING 25 0.0002
707 ANXIETY 46 0.0002
708 PHARYNGITIS 2 0.0002
709 THINKING ABNORMAL 3 0.0002
710 SWELLING 15 0.0002
711 PNEUMONIA ASPIRATION 4 0.0002
712 TUBULOINTERSTITIAL NEPHRITIS 3 0.0002
713 PEMPHIGUS 2 0.0002
714 BLOOD SODIUM DECREASED 3 0.0002
715 DERMATITIS ALLERGIC 2 0.0002
716 COLITIS 6 0.0002
717 FOOT FRACTURE 3 0.0002
718 HAEMATEMESIS 4 0.0002
719 MUSCULOSKELETAL DISORDER 3 0.0002
720 FEELING JITTERY 3 0.0002
721 INJECTION SITE IRRITATION 2 0.0002
722 WHITE BLOOD CELL COUNT INCREASED 6 0.0002
723 POST PROCEDURAL COMPLICATION 3 0.0002
724 GLAUCOMA 3 0.0002
725 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 28 0.0002
726 HERNIA 3 0.0002
727 ANAPHYLACTIC SHOCK 4 0.0002
728 SKIN ULCER 4 0.0002
729 HYPOTENSION 31 0.0002
730 INJECTION SITE INDURATION 2 0.0002
731 OVERDOSE 33 0.0002
732 ANAEMIA 29 0.0002
733 IMMUNE SYSTEM DISORDER 2 0.0002
734 DEPRESSED MOOD 8 0.0002
735 OROPHARYNGEAL PAIN 14 0.0002
736 THERAPEUTIC RESPONSE SHORTENED 5 0.0002
737 BLOOD PRESSURE DECREASED 10 0.0002
738 EAR INFECTION 4 0.0002
739 URINARY RETENTION 5 0.0001
740 DEATH 129 0.0001
741 CARDIAC DISORDER 14 0.0001
742 JOINT RANGE OF MOTION DECREASED 2 0.0001
743 LOSS OF CONSCIOUSNESS 19 0.0001
744 ILL-DEFINED DISORDER 9 0.0001
745 EXTRA DOSE ADMINISTERED 6 0.0001
746 DYSGEUSIA 11 0.0001
747 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 5 0.0001
748 THROAT TIGHTNESS 4 0.0001
749 PSORIATIC ARTHROPATHY 6 0.0001
750 ALOPECIA 29 0.0001
751 INJURY ASSOCIATED WITH DEVICE 3 0.0001
752 MUSCLE SPASMS 27 0.0001
753 INSOMNIA 39 0.0001
754 HOT FLUSH 11 0.0001
755 INJECTION SITE WARMTH 3 0.0001
756 INCORRECT DOSE ADMINISTERED 33 0.0001
757 DIVERTICULITIS 4 0.0001
758 DELIRIUM 5 0.0001
759 MENTAL STATUS CHANGES 4 0.0001
760 ATRIAL FIBRILLATION 14 0.0001
761 PAIN 88 0.0001
762 DERMATITIS 3 0.0001
763 PANCYTOPENIA 8 0.0001
764 COUGH 40 0.0001
765 BLOOD TEST ABNORMAL 2 0.0001
766 HEADACHE 89 0.0001
767 IRRITABLE BOWEL SYNDROME 3 0.0001
768 LIVER FUNCTION TEST INCREASED 3 0.0001
769 RHINORRHOEA 9 0.0001
770 BLOOD CREATINE PHOSPHOKINASE INCREASED 4 0.0001
771 VAGINAL HAEMORRHAGE 6 0.0001
772 INFECTION 20 0.0001
773 HYPOKINESIA 2 0.0001
774 DYSSTASIA 4 0.0001
775 PALPITATIONS 16 0.0001
776 SINUSITIS 14 0.0001
777 NASAL CONGESTION 8 0.0001
778 INFLUENZA 15 0.0001
779 COLITIS ULCERATIVE 6 0.0001
780 RESPIRATORY DISORDER 4 0.0001
781 MUSCULOSKELETAL PAIN 7 0.0001
782 APHASIA 4 0.0001
783 ECONOMIC PROBLEM 2 0.0001
784 GASTROINTESTINAL HAEMORRHAGE 11 0.0001
785 FEELING HOT 8 0.0001
786 EJECTION FRACTION DECREASED 2 0.0001
787 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 26 0.0001
788 SLEEP DISORDER 9 0.0001
789 ARTHRALGIA 53 0.0001
790 ERYTHEMA 26 0.0001
791 DEPRESSED LEVEL OF CONSCIOUSNESS 5 0.0001
792 MEDICATION ERROR 7 0.0001
793 PAIN IN EXTREMITY 37 0.0001
794 NASOPHARYNGITIS 23 0.0001
795 BLISTER 7 0.0001
796 OXYGEN SATURATION DECREASED 7 0.0001
797 TOXICITY TO VARIOUS AGENTS 21 0.0001
798 HIP FRACTURE 4 0.0001
799 SOMNOLENCE 25 0.0001
800 CONFUSIONAL STATE 20 0.0001
801 LIVER INJURY 3 0.0001
802 DYSPNOEA 69 0.0001
803 CONDITION AGGRAVATED 37 0.0001
804 GENERALISED TONIC-CLONIC SEIZURE 2 0.0001
805 VISUAL ACUITY REDUCED 4 0.0001
806 AGEUSIA 3 0.0001
807 HYPOAESTHESIA 18 0.0001
808 VIRAL INFECTION 4 0.0001
809 ROAD TRAFFIC ACCIDENT 5 0.0001
810 BLADDER CANCER 7 0.0001
811 FACE OEDEMA 2 0.0001
812 FLUID RETENTION 6 0.0001
813 PRODUCT QUALITY ISSUE 16 0.0001
814 PNEUMONIA 38 0.0001
815 HEPATIC ENZYME INCREASED 8 0.0001
816 MEMORY IMPAIRMENT 16 0.0001
817 MUSCULOSKELETAL DISCOMFORT 2 0.0001
818 DEVICE DEFECTIVE 2 0.0001
819 PLEURAL EFFUSION 7 0.0001
820 ECZEMA 6 0.0001
821 LOCAL SWELLING 2 0.0001
822 DEVICE USE ISSUE 2 0.0001
823 ALANINE AMINOTRANSFERASE INCREASED 7 0.0001
824 DRUG INTOLERANCE 11 0.0001
825 DERMATITIS ATOPIC 6 0.0001
826 LYMPHOCYTE COUNT DECREASED 2 0.0001
827 LIVER DISORDER 5 0.0001
828 GENERAL PHYSICAL HEALTH DETERIORATION 13 0.0001
829 FALL 37 0.0001
830 PALLOR 3 0.0001
831 DRUG EFFECT INCOMPLETE 4 0.0001
832 RESPIRATORY FAILURE 8 0.0001
833 INTENTIONAL OVERDOSE 7 0.0001
834 AGITATION 8 0.0001
835 RESPIRATORY DISTRESS 3 0.0001
836 ANAPHYLACTIC REACTION 6 0.0001
837 FEELING COLD 3 0.0001
838 AGRANULOCYTOSIS 2 0.0001
839 AMNESIA 7 0.0001
840 EMOTIONAL DISTRESS 13 0.0001
841 UNEVALUABLE EVENT 8 0.0001
842 RENAL CANCER 5 0.0001
843 LOWER LIMB FRACTURE 2 0.0001
844 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 5 0.0001
845 SEIZURE 12 0.0001
846 CONTUSION 10 0.0001
847 LIVER FUNCTION TEST ABNORMAL 3 0.0001
848 EAR PAIN 2 0.0001
849 DYSPHONIA 6 0.0001
850 SURGERY 6 0.0001
851 PSYCHOTIC DISORDER 3 0.0001
852 PYREXIA 35 0.0001
853 DRUG INEFFECTIVE 133 0.0001
854 HAEMATOCRIT DECREASED 2 0.0001
855 AGGRESSION 5 0.0001
856 PSORIASIS 13 0.0001
857 LACRIMATION INCREASED 3 0.0001
858 STOMATITIS 6 0.0001
859 RASH 43 0.0001
860 SWOLLEN TONGUE 3 0.0001
861 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 5 0.0001
862 BRONCHITIS 7 0.0001
863 ASPARTATE AMINOTRANSFERASE INCREASED 5 0.0001
864 CHILLS 11 0.0001
865 JOINT INJURY 2 0.0001
866 MOVEMENT DISORDER 3 0.0001
867 RASH PRURITIC 5 0.0001
868 OSTEONECROSIS 3 0.0001
869 INTENTIONAL PRODUCT USE ISSUE 8 0.0001
870 HAEMATOCHEZIA 5 0.0001
871 ANGIOEDEMA 4 0.0001
872 EXPIRED PRODUCT ADMINISTERED 3 0.0001
873 SKIN DISORDER 3 0.0001
874 DRY SKIN 12 0.0001
875 HEPATOTOXICITY 2 0.0001
876 THROMBOCYTOPENIA 10 0.0001
877 THERAPEUTIC PRODUCT EFFECT DECREASED 4 0.0001
878 THROAT IRRITATION 4 0.0001
879 INJECTION SITE ERYTHEMA 11 0.0001
880 EYE PAIN 5 0.0001
881 ASTHMA 10 0.0001
882 HERPES ZOSTER 5 0.0001
883 THROMBOSIS 7 0.0001
884 EYE IRRITATION 5 0.0001
885 PRODUCT SUBSTITUTION ISSUE 5 0.0001
886 HYPOKALAEMIA 4 0.0001
887 UPPER RESPIRATORY TRACT INFECTION 4 0.0001
888 PERICARDIAL EFFUSION 2 0.0001
889 NEOPLASM PROGRESSION 3 0.0001
890 HEART RATE DECREASED 3 0.0001
891 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 6 0.0001
892 OCULAR HYPERAEMIA 4 0.0001
893 PULMONARY EMBOLISM 8 0.0001
894 DISEASE RECURRENCE 4 0.0001
895 CEREBRAL HAEMORRHAGE 3 0.0001
896 PRODUCTIVE COUGH 4 0.0001
897 HEPATIC CANCER 2 0.0001
898 IRRITABILITY 5 0.0001
899 CRYING 3 0.0001
900 FIBROMYALGIA 2 0.0001
901 NEURALGIA 2 0.0001
902 RESTLESSNESS 3 0.0001
903 ENCEPHALOPATHY 2 0.0001
904 PRODUCT USE IN UNAPPROVED INDICATION 20 0.0001
905 EYE SWELLING 3 0.0001
906 DRY EYE 4 0.0001
907 PRODUCT STORAGE ERROR 7 0.0001
908 DYSARTHRIA 3 0.0001
909 HAEMATOMA 2 0.0001
910 DIPLOPIA 2 0.0001
911 DEAFNESS 2 0.0001
912 ARTHRITIS 6 0.0001
913 JOINT STIFFNESS 2 0.0001
914 BRADYCARDIA 4 0.0001
915 BREAST CANCER FEMALE 2 0.0001
916 CARDIAC FAILURE CONGESTIVE 6 0.0001
917 JAUNDICE 2 0.0001
918 PAIN OF SKIN 2 0.0001
919 DISTURBANCE IN ATTENTION 4 0.0001
920 NEUROPATHY PERIPHERAL 7 0.0001
921 INFLUENZA LIKE ILLNESS 6 0.0001
922 ABNORMAL DREAMS 2 0.0001
923 ARTHROPATHY 4 0.0001
924 CARDIO-RESPIRATORY ARREST 3 0.0001
925 INJURY 5 0.0001
926 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 5 0.0001
927 HAEMOGLOBIN DECREASED 7 0.0001
928 ASCITES 2 0.0001
929 PULMONARY OEDEMA 3 0.0001
930 THERAPEUTIC RESPONSE UNEXPECTED 3 0.0001
931 CORONARY ARTERY DISEASE 2 0.0001
932 LOWER RESPIRATORY TRACT INFECTION 3 0.0001
933 ACNE 5 0.0001
934 SKIN IRRITATION 3 0.0001
935 INJECTION SITE SWELLING 5 0.0001
936 INJECTION SITE RASH 2 0.0001
937 LIMB DISCOMFORT 2 0.0001
938 FEMUR FRACTURE 2 0.0001
939 NERVOUS SYSTEM DISORDER 2 0.0001
940 BONE DENSITY DECREASED 2 0.0001
941 MOOD SWINGS 2 0.0001
942 DEVICE DIFFICULT TO USE 4 0.0001
943 FEBRILE NEUTROPENIA 4 0.0001
944 LIP SWELLING 2 0.0001
945 LEUKOPENIA 3 0.0001
946 NEUTROPENIA 8 0.0001
947 GASTRIC DISORDER 2 0.0001
948 MUSCULOSKELETAL STIFFNESS 5 0.0001
949 HYPOXIA 2 0.0001
950 LYMPHADENOPATHY 2 0.0001
951 PLATELET COUNT DECREASED 6 0.0001
952 PANIC ATTACK 2 0.0001
953 SUICIDAL IDEATION 5 0.0001
954 ADVERSE EVENT 5 0.0001
955 BREAST CANCER 5 0.0001
956 EPISTAXIS 4 0.0001
957 HALLUCINATION 4 0.0001
958 RHEUMATOID ARTHRITIS 6 0.0001
959 BONE PAIN 3 0.0001
960 DRUG DOSE OMISSION BY DEVICE 4 0.0001
961 ABNORMAL BEHAVIOUR 2 0.0001
962 JOINT SWELLING 6 0.0000
963 THERAPEUTIC RESPONSE DECREASED 3 0.0000
964 DYSKINESIA 2 0.0000
965 FLUSHING 5 0.0000
966 NEUTROPHIL COUNT DECREASED 2 0.0000
967 LUNG NEOPLASM MALIGNANT 2 0.0000
968 OSTEOPOROSIS 2 0.0000
969 HAEMORRHAGE 5 0.0000
970 DEEP VEIN THROMBOSIS 3 0.0000
971 DEVICE DISLOCATION 2 0.0000
972 HOSPITALISATION 7 0.0000
973 COGNITIVE DISORDER 2 0.0000
974 INTERSTITIAL LUNG DISEASE 2 0.0000
975 LUNG DISORDER 2 0.0000
976 MALIGNANT NEOPLASM PROGRESSION 4 0.0000
977 ACCIDENTAL EXPOSURE TO PRODUCT 4 0.0000
978 DRUG EFFECT DECREASED 2 0.0000
979 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 2 0.0000
980 DISEASE PROGRESSION 4 0.0000
981 MIGRAINE 3 0.0000
982 MULTIPLE SCLEROSIS RELAPSE 2 0.0000
983 INJECTION SITE REACTION 2 0.0000
984 WHITE BLOOD CELL COUNT DECREASED 3 0.0000
985 NO ADVERSE EVENT 5 0.0000
986 DRUG ABUSE 2 0.0000
987 MATERNAL EXPOSURE DURING PREGNANCY 2 0.0000
988 ADVERSE DRUG REACTION 2 0.0000
989 DRUG DEPENDENCE 2 0.0000